Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-li
资讯
2024-06-12
SHANGHAI, June 11, 2024 (GLOBE NEWSWIRE) - Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to th...